Establishment of epidemiological cutoff values against Fonsecaea monophora , an agent of chromoblastomycosis and cerebral phaeohyphomycosis
Journal of Clinical Microbiology · 2026
DOI: 10.1128/jcm.01846-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Microbiology, 2026. Verfasst von Dallas J Smith und 38 weiteren Autor:innen. Beteiligte Einrichtung: Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Antifungal Agents, Chromoblastomycosis, Fonsecaea, Cerebral Phaeohyphomycosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Brazilian Federal Agency for Support and Evaluation of Gradate Education, Indian Council of Medical Research.
Abstract (Originalsprache)
Fonsecaea monophora is a dematiaceous fungus with worldwide distribution that can cause chromoblastomycosis, an implantation mycosis and a neglected tropical disease. F. monophora also causes phaeohyphomycosis, including central nervous system infections like brain abscesses, with high mortality rates. In the absence of clinical breakpoints, epidemiological cutoff values (ECVs) can aid clinicians in monitoring antifungal resistance trends and guide initial antifungal selection. To establish F. monophora MIC distribution and ECVs, we performed antifungal susceptibility testing (AFST) on F. monophora isolates. AFST data on F. monophora isolates were collected at 14 laboratories during September 2023–May 2026. Species identification was previously confirmed by DNA sequence analysis. AFST was performed by CLSI M38 standard broth microdilution method for itraconazole, voriconazole, posaconazole, isavuconazole, ketoconazole, terbinafine, flucytosine, and amphotericin B. The ECVs were established using the iterative statistical method with ECOFFinder (v2.1) following CLSI M57 guidelines. We analyzed MIC results from 137 F. monophora isolates. The calculated ECVs were itraconazole, 2 μg/mL; voriconazole, 0.25 μg/mL; posaconazole, 1 μg/mL; isavuconazole, 0.25 μg/mL; and terbinafine, 0.5 μg/mL. Amphotericin B and flucytosine had bimodal distributions, and no ECVs were set. Ketoconazole did not have data from ≥100 isolates. These F. monophora ECVs can detect non-wild-type isolates to reevaluate antifungal treatment and investigate treatment failure associated with potential clinical resistance. Established through a global multicenter collaboration, these values provide a baseline to better understand the in vitro antifungal susceptibility profile of this species and monitor resistance. IMPORTANCE Fonsecaea monophora is a dematiaceous fungus with worldwide distribution that can cause chromoblastomycosis, an implantation mycosis and neglected tropical disease of the skin and subcutaneous tissue. F. monophora also causes phaeohyphomycosis, including central nervous system infections like brain abscesses with high mortality rates. The paucity of antifungal susceptibility testing data on F. monophora complicates interpretation of minimum inhibitory concentration (MIC) values. We performed antifungal susceptibility testing on 137 F. monophora isolates to establish MIC distributions and epidemiological cutoff values (ECVs) for eight antifungals, including those commonly used to treat F. monophora infections. The calculated ECVs for commonly used antifungals were 2 μg/mL for itraconazole, 0.25 μg/mL for voriconazole, 1 μg/mL for posaconazole, and 0.5 μg/mL for terbinafine. ECVs can assist in selecting potential treatments for F. monophora and tracking antifungal resistance trends.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
- Westerdijk Fungal Biodiversity Institute, Utrecht, The Netherlands.
- Department of Dermatology and Venerology, Peking University First Hospital, Beijing, China.
- Research Center for Medical Mycology, Peking University, Beijing, China.
- National Clinical Research Center for Skin and Sexually Transmitted Diseases, Beijing, China.
- Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, Beijing, China.
ORCID-Profile: Dallas J Smith, Vania Aparecida Vicente, Vinaykumar Hallur, Sarah E Kidd, Arghadip Samaddar, Anuradha Chowdhary, Arunaloke Chakrabarti, Regielly C R Cognialli, Bram Spruijtenburg, Amir Seyedmousavi, Shawn R Lockhart, Nathan P Wiederhold, Yinggai Song, Ferry Hagen
Förderung
- NIH HHS
- Brazilian Federal Agency for Support and Evaluation of Gradate Education
- Indian Council of Medical Research
- National Institutes of Health
Zitieren
APA
Smith, D. J., van Beurden, T., Li, Y., Almeida-Paes, R., Jacomel, B., Vicente, V. A., Lustosa, B. P. R., Walter, T. H., Neto, E. N. M., Hallur, V., Paul, D., Paul, N., Li, R., Lu, S., Kidd, S. E., Bonifaz, A., Samaddar, A., Treviño-Rangel, R. J., González, G. M., …, & Hagen, F. (2026). Establishment of epidemiological cutoff values against Fonsecaea monophora , an agent of chromoblastomycosis and cerebral phaeohyphomycosis. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01846-25
Vancouver
Smith DJ, van Beurden T, Li Y, Almeida-Paes R, Jacomel B, Vicente VA, et al. Establishment of epidemiological cutoff values against Fonsecaea monophora , an agent of chromoblastomycosis and cerebral phaeohyphomycosis. Journal of Clinical Microbiology. 2026. doi:10.1128/jcm.01846-25
BibTeX
@article{Smith2026,
author = {Smith, Dallas J and van Beurden, Tijmen and Li, Yalong and Almeida-Paes, Rodrigo and Jacomel, Bruna and Vicente, Vania Aparecida and Lustosa, Bruno P R and Walter, Thiago Henrique and Neto, Elias Nunes Monteiro and Hallur, Vinaykumar and Paul, Diptanu and Paul, Nimmy and Li, Ruoyu and Lu, Sha and Kidd, Sarah E and Bonifaz, Alexandro and Samaddar, Arghadip and Treviño-Rangel, Rogelio de J and González, Gloria M and Chowdhary, Anuradha and Brunellie, José Guillermo Pereira and García-Effron, Guillermo and Rudramurthy, Shivaprakash M and Kaur, Harsimran and Chakrabarti, Arunaloke and de Azevedo, Conceicão de Maria Pedrozo E Silva and Marques, Sirlei Garcia and Santos, Daniel Wagner C L and Cognialli, Regielly C R and Queiroz-Telles, Flávio and Spruijtenburg, Bram and Meijer, Eelco F J and de Groot, Theun and Seyedmousavi, Amir and Dufresne, Philippe J and Lockhart, Shawn R and Wiederhold, Nathan P and Song, Yinggai and Hagen, Ferry},
title = {Establishment of epidemiological cutoff values against Fonsecaea monophora , an agent of chromoblastomycosis and cerebral phaeohyphomycosis},
journal = {Journal of Clinical Microbiology},
year = {2026},
doi = {10.1128/jcm.01846-25}
}
EUVIMED